Chester Zygmont's most recent trade in Revelation Biosciences Inc was a trade of 78,145 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Jan. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Chester S. Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.90 per share. | 08 Jan 2026 | 78,145 | 473,790 | - | 0.9 | 70,331 | Common Stock |
| Revelation Biosciences Inc | Chester S. Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 390,614 | 395,645 | - | 1.3 | 499,986 | Common Stock |
| Revelation Biosciences Inc | Chester Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 611 | 0 | - | - | Stock Option (Right to Buy) |